These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32805360)

  • 21. [Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
    Deng LY; Yang ZC; Gong YL; Huang GT; Yin SP; Jiang B; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):523-8. PubMed ID: 27647067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy.
    Mattila S; Ruotsalainen P; Jalasvuori M
    Front Microbiol; 2015; 6():1271. PubMed ID: 26617601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ; Beach ML; Jones RN
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
    Flamm RK; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).
    Mathai D; Lewis MT; Kugler KC; Pfaller MA; Jones RN;
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):105-16. PubMed ID: 11248523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
    Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
    Fritsche TR; Stilwell MG; Jones RN
    Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of blood isolates to various antibiotics, in particular to cephalosporins.
    Ling J; Chau PY; Leung YK; Ng WS
    J Antimicrob Chemother; 1983 May; 11(5):473-80. PubMed ID: 6874632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surveillance of in vitro susceptibilities to levofloxacin and various antibacterial agents for 11,762 clinical isolates obtained from 69 centers in 2013].
    Yamaguchi K; Tateda K; Ohno A; Ishii Y; Murakami H
    Jpn J Antibiot; 2016 Feb; 69(1):1-25. PubMed ID: 27290827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M;
    Jpn J Antibiot; 2012 Jun; 65(3):181-206. PubMed ID: 23173294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
    Ullah O; Khan A; Ambreen A; Ahmad I; Akhtar T; Gandapor AJ; Khan AM
    Arch Iran Med; 2016 Dec; 19(12):866-869. PubMed ID: 27998162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.
    Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H
    Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Research Group for Testing Imipenem Susceptibility on Clinical Isolates].
    Igari J
    Jpn J Antibiot; 1990 Oct; 43(10):1723-82. PubMed ID: 2086814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic Effects of Phage-Antibiotic Combinations against
    Manohar P; Madurantakam Royam M; Loh B; Bozdogan B; Nachimuthu R; Leptihn S
    ACS Infect Dis; 2022 Jan; 8(1):59-65. PubMed ID: 34979073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of genetically diverse Pseudomonas phages enhances the cocktail efficiency against bacteria.
    Naknaen A; Samernate T; Wannasrichan W; Surachat K; Nonejuie P; Chaikeeratisak V
    Sci Rep; 2023 Jun; 13(1):8921. PubMed ID: 37264114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.